DCF — KETTERING HEALTH DAYTON
Enterprise Value: $95.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$95.7M
Enterprise Value
$10.9M
PV of Cash Flows
$84.8M
PV of Terminal Value
$136.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $687.7M | $26.0M | 4.0% | $-5.3M | $-4.8M |
| Year 2 | $708.3M | $33.9M | 5.0% | $-0.2M | $-0.1M |
| Year 3 | $729.5M | $42.2M | 6.0% | $5.3M | $4.0M |
| Year 4 | $751.4M | $47.2M | 6.0% | $8.3M | $5.7M |
| Year 5 | $774.0M | $50.6M | 7.0% | $10.0M | $6.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $95.7M. Terminal value accounts for 89% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$667.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.03282298534968328
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5